Market Overview

Seattle Genetics Presents Data from Phase 1 Clinical Trial of Antibody-Drug Conjugate SGN-CD19A in Non-Hodgkin Lymphoma at ASCO 2014

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News Management Global

 

Related Articles (SGEN)